With a market cap of has a large market cap size. Gilead Sciences Inc. (NASDAQ: GILD) has been on the stock market since its IPO date on the 1/22/1992. Gilead Sciences Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Gilead Sciences Inc., is 10258.4, and so far today it has a volume of 12371500. Performance year to date since the 1/22/1992 is -22.69%.
To help you determine whether Gilead Sciences Inc. is undervalued the following values will help you decide. P/E is 6.82 and forward P/E is 6.63. PEG perhaps more useful shows that Gilead Sciences Inc. has a value for PEG of 85.24. P/S ratio is 3.17 and the P/B ratio is 6.65. The P/Cash and P/Free cash flow is 11.72 and 7.06 respectively.
At the current price Gilead Sciences Inc. is trading at, 77.42 (-1.22% today), Gilead Sciences Inc. has a dividend yield of 2.43%, and this is covered by a payout ratio of 15.20%. Earnings per share (EPS) is 11.35, and this is looking to grow in the next year to -0.80% after growing 62.00% this past year. EPS growth quarter over quarter is -11.50%, and -5.70% for sales growth quarter over quarter.
The number of shares outstanding is 1324.79, and the number of shares float is 1310.68. The senior management bring insider ownership to 0.50%, and institutional ownership is at 80.50%. The float short is 1.33%, with the short ratio at a value of 1.69. Management has seen a return on assets of 32.70%, and also a return on investment of 45.90%.
The ability for Gilead Sciences Inc., to deal with debt, means it current ratio is 1.8, and quick ratio is 1.6. Long term debt/equity is 1.38 and total debt/equity is 1.42. In terms of margins, Gilead Sciences Inc. has a gross margin of 87.10%, with its operating margin at 63.00%, and Gilead Sciences Inc. has a profit margin of 50.50%.
The 52 week high is -30.66%, with -0.21% being its 52 week low. The 20 day simple moving average is -5.83% and the 200 day simple moving average is -13.59%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.